aspsirna0202 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna0202
siRNA Name: siC7/8
Gene:Ataxin-3 (ATXN3)
Disease:Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3)
Wild allele/target (5'->3'): CAGCAGGGGGACCUAUCAGGAC
Mutant allele/target (5'->3'):CAGCAGCCGGACCUAUCAGGAC
Target Mutation: c.G987C,c.892_894CAG(8_36) (p.Gln298_Gln305=)
Wild siRNA (As strand):GUCGUCCCCCUGGAUAGUCCUG
ASP-siRNA (As strand):GUCGUCGGCCUGGAUAGUCCUG
Mismatch position in siRNA: G15C,G16C
Mutant allele (5'->3'): CAGCAGCCGGACCUAUCAGGAC
ASP-siRNA (As strand):GUCGUCGGCCUGGAUAGUCCUG
ASP-siRNA efficacy for mutant allele:80
Wild allele (5'->3'): CAGCAGGGGGACCUAUCAGGAC
ASP-siRNA (As strand):GUCGUCGGCCUGGAUAGUCCUG
ASP-siRNA efficacy for wild allele:20
Percentage discrimination for ASP-siRNA:60
Wild allele (5'->3'): CAGCAGGGGGACCUAUCAGGAC
Wild siRNA (As strand):GUCGUCCCCCUGGAUAGUCCUG
Wild sirna efficacy for wild allele:49
Wild allele (5'->3'): CAGCAGGGGGACCUAUCAGGAC
ASP-siRNA (As strand):GUCGUCGGCCUGGAUAGUCCUG
Wild sirna efficacy for mutant allele:20
Percentage discrimination for wild siRNA:29
Concentration:5mg
Orientation:Sense
Mismatch in:siRNA
UniProt ID: P54252
Target sequence: CAGCAGCAGCAGGGGGACCTATCAGGAC
Genbank Accesion: NM_004993.5
Cell-line: Cos-7
Experimental technique used: Immunoflourescence
Transfection method: Lipofectamine Plus
siRNA expression method: Integrated DNA Technologies
Post-transfection duration: 24-48 hours
OMID ID: 109150
KEGG disease ID:H00063
Reference:12782788

.
.
.
.
.
.
.
.
.
.
.

.

.

.